Cinitapridum

Cinitapridum Uses, Dosage, Side Effects, Food Interaction and all others data.

Cinitapridum is a gastroprokinetic agent and antiulcer benzamide with agonist activity at 5-HT1 and 5-HT4 receptors and antagonist activity at 5-HT2 receptors. It is marketed in Spain and Mexico.

Trade Name Cinitapridum
Generic Cinitapride
Cinitapride Other Names Cinitaprida, Cinitapride, Cinitapridum
Type
Formula C21H30N4O4
Weight Average: 402.4873
Monoisotopic: 402.226705468
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Cinitapridum
Cinitapridum

Uses

Cinitapridum is a benzamide with gastroprokinetic and antiemetic properties typically used for the treatment of gastrointestinal motility disorders such as gastroesophageal reflux disease (GERD), non-ulcer dyspepsia, and delayed gastric emptying.

It is indicated to treat gastrointestinal disorders associated with motility disturbances like gastroesophageal reflux disease (GERD), non-ulcer dyspepsia and delayed gastric emptying.

Cinitapridum is also used to associated treatment for these conditions: Dyspepsia, Flatulence, Gastro-esophageal Reflux Disease (GERD), Gastroesophageal Reflux, Decreased gastrointestinal motility, Meteorism, Mild Dyspepsia, Moderate Dyspepsia

How Cinitapridum works

Cinitapridum is a substituted benzamide with 5-HT receptor antagonist and agonist activity.

Toxicity

The symptoms of overdose include drowsiness, confusion and extrapyramidal effects.

Elimination Route

The absorption of cinitapride (12mg) following oral administration was rapid, with peak levels being achieved 2 h after dosing; absorption following intramuscular administration (4mg) was even more rapid, with peak levels (50% more that oral levels) being achieved 1 h after dosing.

Half Life

3-5 h during the first 8 h and a residual half-life greater than 15 h thereafter.

Innovators Monograph

You find simplified version here Cinitapridum

*** Taking medicines without doctor's advice can cause long-term problems.
Share